Overview

The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat

Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
0
Participant gender:
Female
Summary
Comparison of the effects of Nifedipine and MgSO4 therapies on maternal and fetal blood flow.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Konya Meram State Hospital
Treatments:
Magnesium Sulfate
Nifedipine
Criteria
Inclusion Criteria:

- pregnancies with preterm labor threat between 28-34 weeks gestational ages

Exclusion Criteria:

- Cervical dilatation at > 4 cm and/or cervical effacement >80%,

- Multiple pregnancies,

- Pregnancy complications including preeclampsia, ablatio placenta, intrauterine growth
restriction, placenta previa, gestational diabetes